共 50 条
- [33] SPIRIT study: switching to the single-tablet regimen (STR) of emtricitabine/rilpivirine/tenofovir DF from a ritonavir-boosted protease inhibitor and two nucleoside reverse transcriptase inhibitors maintains HIV suppression and improves serum lipids. PHARMACOTHERAPY, 2012, 32 (10): : E263 - E263
- [34] Coupled blue and red light-emitting diodes therapy efficacy in patients with rosacea: two case reports Journal of Medical Case Reports, 14